Waldemar Debinski

8.2k total citations
174 papers, 6.6k citations indexed

About

Waldemar Debinski is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Waldemar Debinski has authored 174 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Immunology, 48 papers in Molecular Biology and 36 papers in Biotechnology. Recurrent topics in Waldemar Debinski's work include Toxin Mechanisms and Immunotoxins (49 papers), Glioma Diagnosis and Treatment (31 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Waldemar Debinski is often cited by papers focused on Toxin Mechanisms and Immunotoxins (49 papers), Glioma Diagnosis and Treatment (31 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Waldemar Debinski collaborates with scholars based in United States, Canada and China. Waldemar Debinski's co-authors include Denise M. Gibo, Raj K. Puri, Jill Wykosky, Nicholas I. Obiri, Ira Pastan, Stephen B. Tatter, Akiva Mintz, Hui‐Wen Lo, Kounosuke Watabe and G. Yancey Gillespie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Waldemar Debinski

172 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waldemar Debinski United States 45 2.5k 2.3k 1.6k 980 955 174 6.6k
Simone P. Niclou Luxembourg 50 3.2k 1.3× 874 0.4× 1.3k 0.8× 1.7k 1.8× 947 1.0× 113 6.7k
Balveen Kaur United States 56 4.6k 1.9× 1.7k 0.8× 3.0k 1.9× 1.3k 1.3× 256 0.3× 161 8.8k
Alonzo H. Ross United States 57 5.2k 2.1× 1.1k 0.5× 1.6k 1.0× 721 0.7× 1.9k 2.0× 141 8.3k
Kurt S. Zänker Germany 40 2.1k 0.9× 1.3k 0.6× 2.2k 1.4× 253 0.3× 477 0.5× 148 6.1k
Gaetano Finocchiaro Italy 51 3.9k 1.6× 1.2k 0.5× 2.2k 1.4× 3.2k 3.3× 335 0.4× 214 8.2k
Hrvoje Miletić Norway 40 2.5k 1.0× 707 0.3× 1.1k 0.7× 1.7k 1.7× 280 0.3× 118 5.3k
Hamid Band United States 60 6.1k 2.5× 4.0k 1.8× 3.0k 1.9× 543 0.6× 492 0.5× 199 11.4k
Jörg Wischhusen Germany 41 2.7k 1.1× 2.3k 1.0× 2.6k 1.6× 1.4k 1.4× 230 0.2× 91 6.7k
Gregory D. Longmore United States 54 4.3k 1.7× 1.5k 0.7× 2.7k 1.7× 379 0.4× 186 0.2× 133 8.6k
Robert P. Wersto United States 48 4.0k 1.6× 1.4k 0.6× 1.9k 1.2× 299 0.3× 318 0.3× 91 7.1k

Countries citing papers authored by Waldemar Debinski

Since Specialization
Citations

This map shows the geographic impact of Waldemar Debinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldemar Debinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldemar Debinski more than expected).

Fields of papers citing papers by Waldemar Debinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldemar Debinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldemar Debinski. The network helps show where Waldemar Debinski may publish in the future.

Co-authorship network of co-authors of Waldemar Debinski

This figure shows the co-authorship network connecting the top 25 collaborators of Waldemar Debinski. A scholar is included among the top collaborators of Waldemar Debinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldemar Debinski. Waldemar Debinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tao, Farideh Mehraein‐Ghomi, M. Elizabeth Forbes, et al.. (2022). HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion. Molecular Therapy. 30(4). 1610–1627. 11 indexed citations
2.
Robertson, John L., Fang‐Chi Hsu, Martha Larson, et al.. (2022). Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas. Journal of Veterinary Internal Medicine. 36(3). 1066–1074. 7 indexed citations
3.
Hassan, Sazzad, Ashok Pullikuth, Yelena Karpova, et al.. (2020). β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1. Molecular Cancer Research. 18(12). 1839–1848. 8 indexed citations
4.
Renfrow, Jaclyn J., M. Soike, James L. W. West, et al.. (2020). Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Scientific Reports. 10(1). 15195–15195. 23 indexed citations
5.
Xing, Fei, Yin Liu, Shih-Ying Wu, et al.. (2018). Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. 78(15). 4316–4330. 259 indexed citations
6.
Rimkus, Tadas, Richard L. Carpenter, Sherona Sirkisoon, et al.. (2018). Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Research. 78(10). 2589–2600. 32 indexed citations
7.
Mao, Chengqiong, Yan Zhao, Fang Li, et al.. (2018). P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. Journal of Controlled Release. 286. 289–300. 20 indexed citations
8.
Latouche, Eduardo L., et al.. (2017). Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant. Biophysical Journal. 113(2). 472–480. 20 indexed citations
9.
Rossmeisl, John H., et al.. (2017). Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors. OncoTargets and Therapy. Volume 10. 2077–2085. 11 indexed citations
10.
Ferluga, Sara, Roy R. Hantgan, Yehuda Goldgur, et al.. (2013). Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase. Journal of Biological Chemistry. 288(25). 18448–18457. 28 indexed citations
11.
Lively, Mark O., et al.. (2012). EphrinA1 Is Released in Three Forms from Cancer Cells by Matrix Metalloproteases. Molecular and Cellular Biology. 32(16). 3253–3264. 39 indexed citations
12.
Tanaka, Masanori, Waldemar Debinski, & Ishwar K. Puri. (2009). Hybrid mathematical model of glioma progression. Cell Proliferation. 42(5). 637–646. 36 indexed citations
13.
Debinski, Waldemar. (2002). Local Treatment of Brain Tumors with Targeted Chimera Cytotoxic Proteins. Cancer Investigation. 20(5-6). 801–809. 30 indexed citations
14.
Hillman, Gilda G., Gabriel P. Haas, J. Edson Pontes, et al.. (1997). Interleukin-13 Receptors on Human Prostate Carcinoma Cell Lines Represent a Novel Target for a Chimeric Protein Composed of IL-13 and a Mutated Form of Pseudomonas Exotoxin. The Journal of Urology. 948–953. 10 indexed citations
15.
Debinski, Waldemar, Nicholas I. Obiri, Ira Pastan, & Raj K. Puri. (1995). A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4. Journal of Biological Chemistry. 270(28). 16775–16780. 183 indexed citations
16.
Debinski, Waldemar & Ira Pastan. (1994). An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin. Bioconjugate Chemistry. 5(1). 40–46. 32 indexed citations
17.
Debinski, Waldemar, B. Karlsson, Leif Lindholm, et al.. (1992). Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.. Journal of Clinical Investigation. 90(2). 405–411. 31 indexed citations
18.
Debinski, Waldemar, Otto Kuchel, & Nguyen T. Buu. (1990). Atrial natriuretic factor is a new neuromodulatory peptide. Neuroscience. 36(1). 15–20. 23 indexed citations
19.
Debinski, Waldemar, O Küchel, V. F. Castellucci, Jonathan Tremblay, & Pavel Hamet. (1989). Is atrial natriuretic factor anf a ganglionic neurotransmitter. Clinical research. 37(2). 253. 1 indexed citations
20.
Debinski, Waldemar, et al.. (1988). Atrial natriuretic factor in the spinal cord of normotensive and hypertensive rats. Peptides. 9(5). 1101–1105. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone P. Niclou Breakdown of academic impact, for papers by Balveen Kaur Breakdown of academic impact, for papers by Alonzo H. Ross Breakdown of academic impact, for papers by Kurt S. Zänker Breakdown of academic impact, for papers by Gaetano Finocchiaro Breakdown of academic impact, for papers by Hrvoje Miletić Breakdown of academic impact, for papers by Hamid Band Breakdown of academic impact, for papers by Jörg Wischhusen Breakdown of academic impact, for papers by Gregory D. Longmore Breakdown of academic impact, for papers by Robert P. Wersto
Rankless by CCL
2026